Ⓒ 2025 Aurealis Therapeutics. All Rights Reserved.
Aurealis Therapeutics CEO, Juha Yrjänheikki, and COO, Laurent Décory, will be attending the LSX World Congress USA from 16-17 September 2025 in Boston, USA.
Aurealis Therapeutics CEO, Juha Yrjänheikki, and COO, Laurent Décory, will be attending the Biotech Week Boston from 15-18 September 2025 in Boston, USA.
Aurealis Therapeutics team visited China from June 9–13, 2025, for a dedicated partnering week. Juha Yrjänheikki (CEO), Laurent Décory (COO), Hanna-Riikka Kärkkäinen (Director, Quality & Regulatory Affairs), and Jere Kurkipuro
A premier global biotechnology conference for life sciences professionals, held in Basel, Switzerland May 5-6, 2025. Laurent Décory (COO) attended the event and participated in the Microbiome Innovators session.
Symposium on Advanced Wound Care (SAWC) Spring, held April 30–May 4, 2025, in Grapevine, TX. Juha Yrjänheikki (CEO) and Laurent Décory (COO) participated to meet with Advanced Wound Care companies
Symposium on live biotherapeutic products, held in Amsterdam on April 29–30, 2025. Igor Mierau, Director of Genetic Engineering and Manufacturing, participated as a Key Speaker.
Baarerstrasse 21, CH-6300
Zug, Switzerland
Microkatu 1, FI-70210
Kuopio, Finland
This information will only be used to send you our newsletter. You can unsubscribe at any moment.
Ⓒ 2025 Aurealis Therapeutics. All Rights Reserved.